SARS-CoV-2

Asymptomatic individuals are the biggest problem in the COVID battle

Cyclic RNA vaccine shows neutral activity against B.1.351 variant

Research suggests SARS-CoV-2 vaccine circulation strategy with a focus on where virus spreads more easily

ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant

A joint project aims to establish an automated system for the analysis of SARS-CoV-2 in wastewater

The FDA authorizes the first non-diagnostic COVID-19 screening machine based on machine learning

Higher than expected stroke risk in COVID-19 patients

Development of a COVID-19 vaccine using inactivated E. coli

A new variable may not have altered the COVID-19 pandemic course in the UK, a study says

Researchers will study the potential of nanotechnology to deliver therapeutic treatment for COVID-19